KATELYN BONE: Open Payments
NPI 1841871423 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 15 payments from 9 companies in 2025. Trend: 2023 $614 · 2024 $342 · 2025 $610
Food & beverage: $390Education: $220
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $253 |
| AstraZeneca Pharmaceuticals LP | 3 | $150 |
| Janssen Biotech, Inc. | 1 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Merck Sharp & Dohme LLC | 1 | $35 |
| BeOne Medicines USA, Inc. | 1 | $34 |
| Incyte Corporation | 1 | $24 |
| TAIHO ONCOLOGY, INC. | 1 | $21 |
| SOBI, INC | 1 | $18 |
Products named: TECVAYLI, LIBTAYO, KEYTRUDA, BRUKINSA, VERZENIO, ENHERTU, CALQUENCE, JAKAFI.
Industry payments across TX — which companies pay providers there.
